Affiliation:
1. Siberian State Medical University
2. Samara State Medical University
3. Siberian State Medical University;
Territorial Center оf Disaster Medicine of the Tomsk Region
Abstract
Introduction. The article considers the issues of forming a reserve of antibacterial agents designed to eliminate medical and sanitary consequences of emergencies from the perspective of national drug security.Aim. To determine the degree of import substitution of antibacterial agents included in the regional drug reserve.Materials and methods. We carried out a content analysis of data from regulatory documents and research papers related to formation of drug reserves, a logical and structural analysis of the range of antibacterial agents included in the reserve of the Tomsk region, and an analysis of data from the National Drug Register. In the study, we used the Anatomical Therapeutic Chemical (ATC) Classification System of drugs.Results and discussion. It was established that for 19 international nonproprietary names (INN) of antibacterial agents belonging to the group of antibacterials for systemic use (ATC code J01) and forming the reserve of the Tomsk region, 294 brand names (BN) were registered on the pharmaceutical market of the Russian Federation in 2021. The share of registered domestic BN was 49.3 %, and the degree of import dependence of domestic drug manufacturing on foreign-made active pharmaceutical ingredients (APIs) was 81.4 %. It was found that 6 Russian enterprises manufacture APIs that supply production of 10 antibacterial agents included in the drug reserve. A classification of medicines by strategic availability for replenishing the drug reserve was developed. A map on strategic availability of domestically manufactured antibacterial agents included in the reserve was drawn up.Conclusion. We demonstrated high dependence of antibacterial reserve formation on import of this group of medicines and APIs to the Russian Federation. The classification of medicines which takes into account the possibility of replenishing the drug reserve in emergency conditions and if import of medicines stops can be recommended for use by the center for disaster medicine to optimize the nomenclature of drug reserves at various levels from the perspective of national drug security promotion.
Publisher
Center of Pharmaceutical Analytics Ltd
Subject
Drug Discovery,Pharmaceutical Science
Reference16 articles.
1. Chizh I. M., Goryachev A. B., Lemeshchenko E. Y., Afanasev O. N., Kabakova T. I. Modern system of reserves and medical supplies for use in emergency situations. Voenno-meditsinskiy zhurnal. 2017;338(8):60–66. (In Russ.) DOI: 10.17816/RMMJ73456.
2. Belova A. B., Osadchiy K. N., Chubayko V. G., Yuvakaev I. S., Bobiy B. V., Sakhno I. I., Chernyak S. I. Current State and Development Prospects of Regional Disaster Medicine Service According to the 2016–2017 Audit Results. Meditsina Katastrof. 2018;103(3):5–8. (In Russ.) DOI: 10.33266/2070-1004-2018-3-5-8.
3. Goncharov S. F., Bobiy B. V., Akin’shin A. V. Service for Disaster Medicine of Ministry of Health of Russian Federation: Main Results of Activities in 2019 and Tasks for 2020. Meditsina Katastrof. 2020;1:15–27. (In Russ.) DOI: 10.33266/2070-1004-2020-1-15-27.
4. Goncharov S. F., Titov I. G., Bobiy B. V., Akin’shin A. V. Main results of activities of All-Russian Centre for Disaster Medicine "Zashchita" of Federal Medical Biological Agency in 2020 and tasks for 2021. Meditsina Katastrof. 2021;1:10–17. (In Russ.) DOI: 10.33266/2070-1004-2021-1-10-17.
5. Baranova N. N., Goncharov S. F. Current State of the Problem of Organizing and Conducting Medical Evacuation of Victims in Emergencies. Meditsina Katastrof. 2020;4:57–65. (In Russ.) DOI: 10.33266/2070-1004-2020-4-57-65.